Science Explorer Back to mapMap
Discussion
Researcher · Rebecca Sieff Hospital · Israel

Najib Dally

Najib Dally publishes mostly in Hematology, Genetics and Oncology, on topics such as Chronic Lymphocytic Leukemia Research, Multiple Myeloma Research and Treatments and Venous Thromboembolism Diagnosis and Management.

OpenAlex
World rank
#2,295,696
of 7,710,434 ranked researchers
Rank in Israel
#15,148
of 38,292
Works
73
Citations
1.4k
Citations per work
18.6
h-index
15
i10-index 24Top 37% in Hematology
Najib Dally

What does Najib Dally research?

Najib Dally's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 36 works · 49.7% of their workMedicine: 36 works · 49.7% of their workHematology: 13 works · 18.0% of their workGenetics: 9 works · 11.7% of their workOncology: 8 works · 10.7% of their workInternal Medicine: 4 works · 4.9% of their workEpidemiology: 3 works · 4.4% of their workEverything else: 31 works · 43.0% of their workLife Sciences: 5 works · 7.3% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 7.3% of their workMolecular Biology: 5 works · 7.3% of their workTHEIR WORKNajib Dally73works
Life Sciences7%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3649.7%
  2. Everything else3143.0%
    1. Biochemistry, Genetics and Molecular Biology57.3%
  1. 1Hematology18% of their works
  2. 2Genetics12% of their works
  3. 3Oncology11% of their works
  4. 4Molecular Biology7% of their works
  5. 5Internal Medicine5% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Najib Dally's research?

The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Diagnosis Criteria, International Myeloma Working Group, Antithrombotic Therapy and Venous Thromboembolism.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors252 topics
  2. Rituximab252 topics
  3. Chronic Lymphocytic Leukemia161 topic
  4. Genomic Aberrations161 topic
  5. Diagnosis Criteria121 topic
  6. International Myeloma Working Group121 topic
  7. Antithrombotic Therapy101 topic
  8. Venous Thromboembolism101 topic
  9. AML91 topic
  10. Acute Myeloid Leukemia91 topic
  11. Classification91 topic
  12. Lymphoma91 topic
  13. BCR-ABL71 topic
  14. Imatinib71 topic
  15. JAK2 Mutation61 topic
  16. Myelofibrosis61 topic
  17. BET Bromodomains51 topic
  18. PROTACs51 topic

Where does Najib Dally work?

Najib Dally's main affiliation in the publication record is Rebecca Sieff Hospital, Israel.

How many publications and citations does Najib Dally have?

OpenAlex counts 73 works and 1,359 citations for Najib Dally, an h-index of 15, ranking #2,295,696 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Najib Dally. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.